Takeda Pharmaceutical Co Ltd has revised its financial forecast for FY2025, expecting a revenue of JPY 4,500 billion, down by JPY 30 billion, and a net profit of JPY 153 billion, a drop of 32.9% from the original outlook; these changes reflect operational challenges and strategic decisions made as of October 30, 2025.